- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07937267
Cytological Assessment of Donor-Site Healing After Free Gingival Grafting
Cytological Evaluation of the Effects of Different Donor-Site Interventions on Healing After Free Gingival Graft Surgery
An adequate width of keratinized gingiva is important for maintaining periodontal and peri-implant tissue health. Free gingival grafting (FGG) is a commonly performed surgical procedure for increasing insufficient keratinized gingival width. This study aims to evaluate the effect of applying a chitosan sponge to the palatal donor site on wound healing after FGG using exfoliative cytology and to compare the findings with those obtained from a control group in which no chitosan sponge is applied.
At least 40 patients scheduled to undergo FGG because of insufficient keratinized gingival width will be included. The patients will be allocated to two groups: a test group and a control group. In the test group, a chitosan sponge will be applied to the palatal donor site, whereas no wound dressing will be applied to the palatal donor site in the control group. The primary outcome will be the keratinization index determined from cytological samples collected from the palatal donor site at one month after surgery. The keratinization index values at one month will be compared between the test and control groups.
All participants will receive detailed information about the study and the procedures, and written informed consent will be obtained. Clinical measurements will be recorded before surgery, after which the FGG procedure will be performed. Depending on group allocation, the palatal donor site will either be treated with a chitosan sponge or left without a wound dressing. Sutures will be removed on postoperative day 10.
For exfoliative cytological assessment, baseline samples will be collected from both the planned palatal donor site and the contralateral symmetrical healthy palatal site, which will not undergo surgery, in all patients. Samples collected from the symmetrical palatal site will serve as a reference for the baseline characteristics of healthy palatal mucosa. Follow-up samples will be collected exclusively from the palatal donor site on postoperative day 3,10 and at 1, 3, and 6 months. The keratinization index and other cellular features associated with wound healing will be assessed in the cytological samples. Findings obtained during the follow-up periods will be compared between the test group treated with a chitosan sponge and the control group in which no wound dressing is applied. In addition, the presence or absence of sensory loss at the palatal donor site will be evaluated using a periodontal probe.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Istanbul, Turquia (Türkiye)
- Recrutamento
- Biruni University
-
Contato:
- Ayşe Ege Selman
- Número de telefone: 902124448276
- E-mail: ayseegeselman@gmail.com
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Volunteering to participate in the study,
- Being at least 18 years of age,
- The need for SDG in patients with < 2 mm of keratinized gingiva on the vestibular side of the implant/tooth,
- No prior surgical procedures or grafts in the palatal region,Volunteering to participate in the study,
Exclusion Criteria:
- The presence of a systemic disease that would contraindicate surgical treatment,
- Uncontrolled diabetes (HbA1c > 7),
- Pregnancy or breastfeeding,
- Autoimmune and/or inflammatory diseases of the oral cavity,
- Active periodontal disease.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: Ao controle
|
Free gingival graft surgery |
|
Experimental: Teste
|
Free gingival graft surgery Suturing of chitosan sponge to the palatal donor site |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Palatal donor site tissue thickness:
Prazo: Pre-operative
|
The thickness of the donor site will be measured using an endodontic reamer. |
Pre-operative
|
|
Palatal donor site tissue thickness:
Prazo: immediate Post-operative
|
The thickness of the donor site will be measured using an endodontic reamer. |
immediate Post-operative
|
|
Palatal donor site tissue thickness:
Prazo: day 10
|
The thickness of the donor site will be measured using an endodontic reamer. |
day 10
|
|
Palatal donor site tissue thickness:
Prazo: day 30
|
The thickness of the donor site will be measured using an endodontic reamer. |
day 30
|
|
Palatal donor site tissue thickness:
Prazo: day 90
|
The thickness of the donor site will be measured using an endodontic reamer. |
day 90
|
|
Palatal donor site tissue thickness:
Prazo: day 180
|
The thickness of the donor site will be measured using an endodontic reamer. |
day 180
|
|
Keratinization Index
Prazo: day 3
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 3
|
|
Keratinization Index
Prazo: day 10
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 10
|
|
Keratinization Index
Prazo: day 30
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 30
|
|
Keratinization Index
Prazo: day 90
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 90
|
|
Keratinization Index
Prazo: day 180
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 180
|
|
Superficial cell index
Prazo: day 3
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 3
|
|
Superficial cell index
Prazo: day 10
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 10
|
|
Superficial cell index
Prazo: day 30
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 30
|
|
Superficial cell index
Prazo: day 90
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 90
|
|
Superficial cell index
Prazo: day 180
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 180
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Loss of sensation
Prazo: Day 10
|
To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping. |
Day 10
|
|
Loss of sensation
Prazo: Day 30
|
To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping. |
Day 30
|
|
Loss of sensation
Prazo: Day 90
|
To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping. |
Day 90
|
|
Loss of sensation
Prazo: Day 180
|
To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping. |
Day 180
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Outros números de identificação do estudo
- 2015-KAEK-80-23-44
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .